Braun Stacey Associates Inc. decreased its position in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) by 26.0% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 4,550 shares of the pharmacy operator’s stock after selling 1,600 shares during the quarter. Braun Stacey Associates Inc.’s holdings in Walgreens Boots Alliance were worth $288,000 as of its most recent SEC filing.
A number of other institutional investors have also recently added to or reduced their stakes in the business. Oregon Public Employees Retirement Fund increased its stake in shares of Walgreens Boots Alliance by 12,422.1% in the 4th quarter. Oregon Public Employees Retirement Fund now owns 34,807,507 shares of the pharmacy operator’s stock valued at $509,000 after acquiring an additional 34,529,539 shares in the last quarter. Norges Bank bought a new stake in shares of Walgreens Boots Alliance in the 4th quarter valued at $589,781,000. Boston Partners increased its stake in shares of Walgreens Boots Alliance by 3,449.3% in the 4th quarter. Boston Partners now owns 3,973,944 shares of the pharmacy operator’s stock valued at $271,540,000 after acquiring an additional 3,861,981 shares in the last quarter. Morgan Stanley increased its stake in shares of Walgreens Boots Alliance by 49.8% in the 3rd quarter. Morgan Stanley now owns 6,248,967 shares of the pharmacy operator’s stock valued at $455,550,000 after acquiring an additional 2,077,270 shares in the last quarter. Finally, APG Asset Management N.V. increased its stake in shares of Walgreens Boots Alliance by 66.2% in the 4th quarter. APG Asset Management N.V. now owns 3,740,281 shares of the pharmacy operator’s stock valued at $223,569,000 after acquiring an additional 1,489,401 shares in the last quarter. Hedge funds and other institutional investors own 64.77% of the company’s stock.
WBA has been the subject of several research analyst reports. Loop Capital lowered their price objective on shares of Walgreens Boots Alliance to $77.00 and set a “buy” rating for the company in a research note on Wednesday, March 27th. They noted that the move was a valuation call. TheStreet lowered shares of Walgreens Boots Alliance from a “b-” rating to a “c+” rating in a research note on Friday, March 29th. Morgan Stanley lowered their price objective on shares of Walgreens Boots Alliance from $77.00 to $67.00 and set an “equal weight” rating for the company in a research note on Tuesday, March 5th. Barclays reduced their price target on shares of Walgreens Boots Alliance from $78.00 to $60.00 and set an “equal weight” rating for the company in a research report on Wednesday, April 3rd. Finally, Mizuho set a $67.00 price target on shares of Walgreens Boots Alliance and gave the company a “hold” rating in a research report on Thursday, March 28th. Five research analysts have rated the stock with a sell rating, thirteen have assigned a hold rating and four have given a buy rating to the company’s stock. Walgreens Boots Alliance has a consensus rating of “Hold” and a consensus target price of $68.00.
In other Walgreens Boots Alliance news, COO Ornella Barra bought 18,000 shares of the stock in a transaction dated Wednesday, April 3rd. The shares were bought at an average cost of $54.56 per share, for a total transaction of $982,080.00. Following the purchase, the chief operating officer now directly owns 26,425 shares of the company’s stock, valued at approximately $1,441,748. The purchase was disclosed in a document filed with the SEC, which can be accessed through this link. Also, CAO Marco Patrick Anthony Pagni sold 20,000 shares of Walgreens Boots Alliance stock in a transaction on Thursday, May 9th. The stock was sold at an average price of $53.05, for a total value of $1,061,000.00. Following the sale, the chief accounting officer now owns 435,811 shares in the company, valued at $23,119,773.55. The disclosure for this sale can be found here. 15.73% of the stock is owned by insiders.
WBA traded up $0.18 during mid-day trading on Wednesday, reaching $52.94. 2,928,450 shares of the stock were exchanged, compared to its average volume of 6,516,903. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.78 and a quick ratio of 0.38. The company has a market capitalization of $48.40 billion, a price-to-earnings ratio of 8.79, a P/E/G ratio of 1.06 and a beta of 0.77. Walgreens Boots Alliance Inc has a 1 year low of $51.79 and a 1 year high of $86.31.
Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings data on Tuesday, April 2nd. The pharmacy operator reported $1.64 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $1.70 by ($0.06). The firm had revenue of $34.53 billion for the quarter, compared to analysts’ expectations of $34.57 billion. Walgreens Boots Alliance had a return on equity of 22.00% and a net margin of 3.77%. Walgreens Boots Alliance’s revenue was up 4.6% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.73 earnings per share. As a group, equities analysts anticipate that Walgreens Boots Alliance Inc will post 5.99 EPS for the current year.
The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, June 12th. Shareholders of record on Monday, May 20th will be issued a dividend of $0.44 per share. This represents a $1.76 dividend on an annualized basis and a yield of 3.32%. The ex-dividend date of this dividend is Friday, May 17th. Walgreens Boots Alliance’s dividend payout ratio is 29.24%.
COPYRIGHT VIOLATION WARNING: “Walgreens Boots Alliance Inc (NASDAQ:WBA) Stake Lowered by Braun Stacey Associates Inc.” was originally reported by Sundance Herald and is the sole property of of Sundance Herald. If you are reading this piece on another website, it was stolen and republished in violation of US & international trademark & copyright laws. The correct version of this piece can be accessed at https://sundanceherald.com/2019/05/22/braun-stacey-associates-inc-has-288000-stake-in-walgreens-boots-alliance-inc-wba.html.
About Walgreens Boots Alliance
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.
Featured Article: What is Depreciation?
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.